Organogenesis Holdings
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Organogenesis Holdings generated cash of $30,917,000, which is more than the previous year. Cash used in financing activities reached the amount of -$5,505,000 last year. Net change in cash is therefore $1,048,000.
Cash Flow
| 2015 | -10.19M | -389K | 10.78M |
|---|---|---|---|
| 2016 | -562.23K | -310M | 311.47M |
| 2017 | -586.60K | -14.87M | -327.57K |
| 2018 | -60.73M | -1.85M | 81.64M |
| 2019 | -33.52M | -6.23M | 78.72M |
| 2020 | 6.80M | -24.83M | 42.46M |
| 2021 | 61.97M | -31.22M | -1.03M |
| 2022 | 24.85M | -33.89M | -2.19M |
| 2023 | 30.91M | -24.36M | -5.50M |
ORGO Cash Flow Statement (2015 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 103.29M | 114.52M | 84.80M | 60.37M | 21.40M | 2.35M | 1.04M | 126.06K | 995K |
Operating activities | |||||||||
Net income | 4.94M | 15.53M | 94.90M | 17.94M | -40.45M | -64.83M | -2.09M | -208.69K | -24.26M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||||||
Depreciation and amortization | 23.44M | 18.03M | 16.67M | 7.46M | 9.43M | 6.97M | 5.62M | 7.31M | 7.68M |
Stock-based compensation expense | 8.99M | 6.55M | 3.86M | 1.66M | 936K | 0 | 919K | 473K | 459K |
| Deferred income tax benefit | 8.99M | 6.55M | 3.86M | 1.66M | 936K | 0 | 919K | 473K | 459K |
| Changes in operating assets and liabilities: | |||||||||
Accounts receivable, net | 5.53M | -8.77M | -30.23M | -18.82M | -4.69M | -7.11M | -7.01M | -6.55M | 1.40M |
Inventories | 6.58M | -9.41M | -9.30M | -6.7M | -11.06M | -5M | -1.49M | -5.36M | -8.19M |
Accounts payable | -108K | 3.26M | 3.84M | -635K | 4.7M | -60K | 0 | 0 | 0 |
Cash generated by operating activities | 30.91M | 24.85M | 61.97M | 6.80M | -33.52M | -60.73M | -586.60K | -562.23K | -10.19M |
Investing activities | |||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -24.36M | -33.89M | -31.22M | -21.14M | -6.23M | -1.85M | -2.42M | -1.36M | -510K |
Acquisitions Net | 0 | 0 | 0 | -5.82M | 0 | 1K | -11.79M | 0 | 0 |
Cash generated by investing activities | -24.36M | -33.89M | -31.22M | -24.83M | -6.23M | -1.85M | -14.87M | -310M | -389K |
Financing activities | |||||||||
Common Stock Issued | 0 | 2.07M | 2.19M | 64.72M | 50.34M | 92M | -427.57K | 303.8M | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | -648K | -737K | 0 | -6.76M | 0 | 0 | 0 | 0 |
Repayments of term debt | -5.17M | -3.01M | -65.18M | -25.91M | 37.22M | -22.69M | 100K | -300K | 0 |
Cash used in financing activities | -5.50M | -2.19M | -1.03M | 42.46M | 78.72M | 81.64M | -327.57K | 311.47M | 10.78M |
Net Change In Cash | 1.04M | -11.23M | 29.72M | 24.43M | 38.96M | 19.04M | -914.18K | 914.00K | 204K |
Cash at end of period | 104.33M | 103.29M | 114.52M | 84.80M | 60.37M | 21.40M | 125.88K | 1.04M | 1.19M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |